DNM1L and Nephropathy: A recent study showed that emodin inhibited the kinase activity of calcium/calmodulin-dependent protein kinase II, preventing its phosphorylation of Drp1 at the Ser616 site to alleviate I/R-induced kidney damage (Wang et al., 2022d).